Low-Cysteine Diets May Curb Hunger and Aid Weight Loss, Study Finds

A new study from NYU Grossman School of Medicine has uncovered how diets low in sulfur-containing amino acids, particularly cysteine, could help manage weight. Researchers found that mice lacking cysteine lost significant body weight, but the effects went beyond simple calorie restriction. The work also sheds light on why hunger signals remain heightened long after dieting stops.

In 2023, the team discovered that mice unable to produce cysteine and fed a cysteine-free diet lost 30% of their body weight within a week. The deficiency disrupted normal metabolic processes, forcing the animals to burn fat reserves for energy. However, complete cysteine deprivation left organs more vulnerable to common toxins.

Low cysteine levels also reduced coenzyme A (CoA), which is essential for converting carbohydrates and fats into usable energy. This metabolic shift suggested potential benefits from a controlled low-sulfur diet rather than total deprivation.

Earlier research had already shown that dieting amplifies hunger signals in the brain. Mice on restricted diets experienced long-lasting changes in neural pathways, causing them to eat more and regain weight quickly once normal feeding resumed. In this latest study, scientists successfully blocked these overactive hunger signals in mice, preventing rapid weight regain after dieting.

The findings build on a separate 2023 discovery by the same institution, published in Nature, which identified a gut hormone combination mimicking the effects of bariatric surgery. That breakthrough led to clinical trials, including a phase 2 study launched in 2024 (NCT06234962), testing oral hormone therapies for obesity. By 2026, experimental multi-hormone treatments had reduced weight by up to 20% in human trials.

The research highlights the complex role of cysteine in metabolism and appetite regulation. By targeting specific neural circuits and dietary components, scientists aim to develop more effective weight management strategies. Clinical trials based on related hormone therapies are already showing promise in human studies.